![2-Methylcitric acid l-1-yl)methyl]benzoic acid-d3 Formula: C19H18N2](https://cdn.shopify.com/s/files/1/0389/1897/9723/products/M26314_1635976302.gif?v=1635976303)
Pay in 4 interest-free payments of $29.75 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Formula: C19H18N2
IC50 value:Target: AMPAR modulatorin vitro: PEPA dose-dependently potentiated AMPA-induced increase of [Ca2+]i
Thalidomide D4 is a deuterium labeled Thalidomide
InChi: InChI=1S/C31H34ClN3O7S3/c1-22(2)28-21-43-30(34-28)20-42-25-9-7-8-23(18-25)19-35(45(40
InChi: InChI=1S/C10H13N5O5/c11-7-4-8(14-10(19)13-7)15(2-12-4)9-6(18)5(17)3(1-16)20-9/h2-3
2-Methylcitric acid l-1-yl)methyl]benzoic acid-d3 Formula: C19H18N22 Methylcitric acid (Methylcitric acid) is an endogenous metabolite in the 2 methylcitric acid cycle. 2 Methylcitric acid accumulates in methylmalonic and propionic acidemias and acts as a marker metabolite. 2 Methylcitric acid markedly inhibits ADP stimulated and uncoupled respiration in mitochondria supported by glutamate. Product information CAS Number: 6061 96 7 Molecular Weight: 206. 15 Formula: C7H10O7 Chemical Name: 2 hydroxy 1 methylpropane